BioWorld

May 31, 2002

Biotech Officials Push Harder To Get FDA Leader Appointed

WASHINGTON - Every now and then when a drug doesn't win FDA approval, someone in the background can be heard blaming the failure on a lack of leadership at the government agency. (BioWorld Today) Read More

Visible Genetics Considers Sale Of Company, Lowers Estimates

Nearly Complete Draft Of Mouse Genome Underlines Similarities To Human Genetic Complement

Agennix Raises $20M Privately, Prepares For Clinical Explosion

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for April 10, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for April 7, 2026

MMP inhibitors divulged in Accure Therapeutics patent

BioWorld Science

Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...

MSD discloses new HCN1/2 blockers

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...

Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

BioWorld Science

Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...